DeutschNewstral
Article
The Globe and Mail on 2016-06-14 22:45
Health Canada clarifies stance on synthetic opioid W-18
Related news
- Why Health Canada must reclassify tramadol as an opioidThe Globe and Mail
Health Canada clarifies eligibility for seniors under national dental care planCBC- Mulcair clarifies stance on niqab at citizenship ceremoniesThe Globe and Mail
Health Canada To Relax Rules On Prescription Heroin To Treat Opioid Addictionhuffingtonpost.ca
Canada clarifies its stance on a ‘humanitarian truce’POLITICO
The crucial opioid interventions Canada needs nownews.ubc.ca- Prescriptions of opioid drugs skyrocketing in CanadaThe Globe and Mail
Brown v. Canada Clarifies Obligations of Patent Applicantsjdsupra.com- Canada Revenue Agency clarifies timeline of new TFSA limitThe Globe and Mail
- Canada Clarifies and Expands Proposal for Equity Buyback Taxjdsupra.com
‘Stronger than fentanyl’: The surge in seizures of a deadly new synthetic opioidSydney Morning Herald
Canada women’s coach ‘proud’ of team’s stance during pay disputeThe Japan Times
Canada Takes Tougher Stance With China Over Detentionswsj.com- Hockey Canada clarifies incidents reported to Sport Canada after discrepancy at committeeCBC
- It’s time Canada reassessed its stance on selling waterThe Globe and Mail
- Obama expects Canada to sign TPP despite Liberals’ reserved stanceThe Globe and Mail
Dugdale clarifies independence stanceBBC- Health Canada eyes opioid restrictions for popular painkiller tramadolThe Globe and Mail
- VSettlement reached with Purdue Pharma (Canada) for opioid damagesvoiceonline.com